Supporting Innovation Through Our US Capability.
LORAI Health launches research and business operations in the US, supporting the company's global development strategy.
Our operational footprint reflects the international nature of healthcare innovation and enables collaboration across research, technology, manufacturing and commercialisation.
Through activities in both countries, LORAI Health is building the foundations required to support the development of next generation transdermal technologies for global markets.
LORAI Health LLC supports the company's research and business activities within the United States.
Our US operations provide access to scientific expertise, innovation infrastructure and strategic partnerships that support the advancement of both our technology platforms and our long-term growth objectives.
Delaware Innovation Space
We conduct activities through the Delaware Innovation Space, a leading innovation ecosystem supporting science and technology companies.
This environment provides us with access to research infrastructure, industry networks and collaborative opportunities that support the development of our advanced healthcare technologies.
LORAI Health LLC's US based research and development activities are focused on developing the company's Gen-2 transdermal platform.
These activities contribute to the ongoing evaluation of next generation approaches to transdermal drug delivery, with a focus on improving patient experience, treatment continuity and future manufacturing capability.
Our research programs are conducted in collaboration with scientific advisors, technical specialists and industry partners as appropriate.
US Operations
US Leadership
-
Dr Raisa Monteiro
CHIEF EXECUTIVE OFFICER
-
Dr Alex Ionkin
CHIEF TECHNOLOGY OFFICER